Publication: Arsenic Exposure and Neurodevelopmental Disorders in Children: A Cross-Sectional Study
| dc.contributor.author | López, Claudia | |
| dc.contributor.author | Rubilar, Paola | |
| dc.contributor.author | Muñoz, María P. | |
| dc.contributor.author | Hirmas, Macarena | |
| dc.contributor.author | Iglesias, Verónica | |
| dc.date.accessioned | 2026-09-08T14:38:37Z | |
| dc.date.available | 2026-09-08T14:38:37Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Introduction: Arsenic exposure has been identified as a possible risk factor for neurodevelopmental disorders (NDDs). In Arica, research has been conducted to relate arsenic exposure to the prevalence of attention deficit hyperactivity disorder (ADHD). However, highlighting the need to explore other events, such as autism spectrum disorder (ASD), this study aimed to evaluate the association between current urinary arsenic concentration and the prevalence of NDDs in children from Arica. Methods: A cross-sectional study was conducted using secondary data from the FONIS project #SA22I0119. The sample consists of 450 children born between 2013 and 2016. The outcome variable, diagnosis of NDDs, was measured through parent self-reporting. The exposure variable corresponds to the current concentration of urinary inorganic arsenic, corrected by creatinine. A logistic regression model adjusted for confounding variables was used. Results: According to parent self-report, the prevalence of ADHD was 9.1%, ASD 5.3%, and NDDs 12%. The mean urinary inorganic arsenic concentration was 19.8 μg/g creatinine, and 7.6% of the children had levels ≥35 μg/g creatinine. After adjusting for tutors’education, number of household members, sex, and indigenous origin, those children with urinary arsenic ≥ 35 μg/g creatinine were more likely to present some NDDs (OR: 2.93; 95% CI 1.11, 7.75). For ADHD, the association was also elevated (OR = 3.85; 95% CI 1.44, 10.29). Conclusion: The findings suggest an association between arsenic exposure and the prevalence of NDDs in children. These results contribute to the evidence of arsenic’s effect on the neurodevelopment of the child population. | |
| dc.description.version | Versión publicada | |
| dc.format.extent | 15 p. | |
| dc.identifier.citation | López C, Rubilar P, Muñoz MP, Hirmas-Adauy M, Iglesias V. Arsenic Exposure and Neurodevelopmental Disorders in Children: A Cross-Sectional Study. Annals of Global Health. 2025; 91(1): 90, 1– 15. DOI: https://doi.org/10.5334 /aogh.4874 | |
| dc.identifier.doi | https://doi.org/10.5334 /aogh.4874 | |
| dc.identifier.uri | https://hdl.handle.net/11447/11087 | |
| dc.language.iso | en | |
| dc.rights | Atribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL) | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/cl/ | |
| dc.subject | Arsenic | |
| dc.subject | Neurodevelopmental disorders | |
| dc.subject | Children | |
| dc.subject | Exposure | |
| dc.title | Arsenic Exposure and Neurodevelopmental Disorders in Children: A Cross-Sectional Study | |
| dcterms.accessRights | Acceso abierto | |
| dcterms.source | Annals of Global Health | |
| dspace.entity.type | Publication |